FASN and neoplasm: One study showed that the PI3k-α-specific inhibitor CYH33 facilitates the infiltration and activation of T cells by promoting FASN-mediated fatty acid metabolism while weakening the proliferation of M2-like macrophages and Treg cells; this boosts host immunity and inhibits tumor growth [77].